Dr. Bruce N Riger, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 475 Bruce St Ste 700, Yreka, CA 96097 Phone: 530-842-9800 Fax: 530-842-9054 |
Sean S Park, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 444 Bruce St, Yreka, CA 96097 Phone: 702-453-3799 Fax: 702-453-5741 |
Auyporn Dansunankul, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 444 Bruce St, Yreka, CA 96097 Phone: 530-842-4121 |
Rachel R Dunn-black, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 475 Bruce Street, Suite 700, Yreka, CA 96097 Phone: 530-842-3261 Fax: 530-842-7899 |
Dr. Kien Tran, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 475 Bruce St, Yreka, CA 96097 Phone: 530-842-3507 |
Dr. Moudy Samir Youssef, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 475 Bruce St, Yreka, CA 96097 Phone: 530-842-3507 Fax: 530-842-9412 |
News Archive
In a move designed to strengthen the delivery and quality of health care in northwest North Dakota, Mayo Clinic today welcomes Trinity Health as the newest member of the Mayo Clinic Care Network. As a member of the network, Trinity Health's physicians and other providers will have direct access to Mayo Clinic experts and clinical resources.
Knopp Neurosciences Inc. announced that it received Fast Track designation from the U.S. Food and Drug Administration (FDA) for the development of KNS-760704 in amyotrophic lateral sclerosis (ALS).
PAREXEL International Corporation announced today that its Board of Directors has approved a stock repurchase program authorizing the repurchase of up to $200 million of the Company's common stock, subject to the consent of the Company's lenders.
A New York Institute of Technology research team led by Olga V. Savinova, Ph.D., assistant professor of biomedical sciences at New York Institute of Technology College of Osteopathic Medicine, has secured a five-year grant from the National Institutes of Health National Heart, Lung, and Blood Institute.
BASF SE has reached an agreement with Cognis Holding Luxembourg S.a r.l. controlled by Permira Funds, GS Capital Partners and SV Life Sciences to acquire the specialty chemicals company Cognis for an equity purchase price of euro 700 million. Including net financial debt and pension obligations, the enterprise value of the transaction is euro 3.1 billion. The acquisition is subject to clearance by the competent merger control authorities. Closing of the transaction is expected for November 2010 at the latest.
› Verified 3 days ago